Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays

Rapid tests for SARS-COV-2 infection are important tools for pandemic control, but current rapid tests are based on proprietary designs and reagents. We report clinical validation results of an open-access lateral flow assay (OA-LFA) design using commercially available materials and reagents, along...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachman, Christine M., Grant, Benjamin D., Anderson, Caitlin E., Alonzo, Luis F., Garing, Spencer, Byrnes, Sam A., Rivera, Rafael, Burkot, Stephen, Ball, Alexey, Stafford, James W., Wang, Wenbo, Banik, Dipayan, Keller, Matthew D., Cate, David M., Nichols, Kevin P., Weigl, Bernhard H., Dewan, Puneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370603/
https://www.ncbi.nlm.nih.gov/pubmed/34403456
http://dx.doi.org/10.1371/journal.pone.0256352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370603/
https://www.ncbi.nlm.nih.gov/pubmed/34403456
http://dx.doi.org/10.1371/journal.pone.0256352

Ejemplares similares